Retraction

Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer

Paper Information

Record ID:
30867
Author(s):
Juan Gu
Yueping Wang
Xuedong Wang
Daoping Zhou
Chaopeng Shao
Ming Zhou
Zhimin He
Journal:
Cancer Letters ( Elsevier )
Publication Date:
June 30, 2018
Retraction Date:
July 14, 2021 (4.3 years years ago)
Subjects:
Broad Categories:
Biology
Institutions:
Countries:
🇨🇳 China 🇺🇸 United States
Article Type:
Research Article
Publisher:
Elsevier
Open Access:
Yes
DOI:
10.1016/j.canlet.2018.06.039
PubMed ID:
29969658
Retraction PubMed ID:
Not indexed in PubMed

Retraction Details

Retraction Reasons:
Nature of Retraction:

Retraction

Retraction Notice:
10.1016/j.canlet.2021.07.004
Additional Notes:

see also: https://pubpeer.com/publications/CD2145749587F611DC205044C439FE

Citations (129)

129
Total Citations
40
Post-Retraction
(31.0%)
88
Pre-Retraction
1
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
12 Within 1 year
24 After 2+ years
861 Days since retraction (latest)
MiR-622 Expression and Role in Multiple Tumors
J.F. Hopkins, Mohammad Javed Ali, Safar Zadeh
Authorea (Authorea) Open Access
Published: Nov 2023
861 days after retraction
New understanding of exosomes as a miRNA delivery mechanism has led to advances in RNA cancer treatments
Jessica Harris
Authorea (Authorea) Open Access
Published: Nov 2023
861 days after retraction
microRNAs linked to anthracycline-induced cardiotoxicity in breast cancer patients' female partners: a meta-analysis and route study
Debeshmita Pazhan, Debeshmita Pazhan, Sunny Lira et al. (5 authors)
Authorea (Authorea) Open Access
Published: Nov 2023
859 days after retraction
Review From the lab to the hospital: new ideas in miRNA medicine
H. S. Khalil, H. S. Khalil
Authorea (Authorea) Open Access
Published: Nov 2023
859 days after retraction
A brief overview of the role of microRNA-338 in carcinogenesis
Christopher Hugh, Christopher Hugh, Kathrine Mentho
Authorea (Authorea) Open Access
Published: Nov 2023
859 days after retraction
miRNA: A Potential Breast Cancer Treatment? How did we get here?
C. Bush
Authorea (Authorea) Open Access
Published: Nov 2023
859 days after retraction
The role of long non-coding RNAs in the spread of breast cancer
Carol Doss
Authorea (Authorea) Open Access
Published: Nov 2023
1 citation
859 days after retraction
The growing relevance of microRNAs as a diagnostic marker for breast cancer
D. Moher, Frank Mosby, Lisa V. Smith
Authorea (Authorea) Open Access
Published: Nov 2023
859 days after retraction
Biomarkers for the (cancer-related) risk of thrombosis in the veins: microRNAs
Mahmoud Feysal, Mahmoud Feysal
Authorea (Authorea) Open Access
Published: Nov 2023
859 days after retraction
New therapeutic axis in blood malignancies involving microRNAs and JAK/STAT3 signaling
George House
Authorea (Authorea) Open Access
Published: Nov 2023
855 days after retraction
Transcriptomic insights into the development and therapy of breast cancer via the ncRNA-mediated ceRNA regulation network
Jim Al Khaled
Authorea (Authorea) Open Access
Published: Nov 2023
855 days after retraction
Nano-therapeutic targeting of the tumor microenvironment in metastatic breast cancer: Current state and future prospects
A Hansen, Erik Aaberg, Hakon Landvik
Authorea (Authorea) Open Access
Published: Nov 2023
855 days after retraction
Applications of the p53/MicroRNA-34 axis beyond cancer
James Schwartzberg, James Schwartzberg
Authorea (Authorea) Open Access
Published: Nov 2023
855 days after retraction
Implications for precision medicine and the reciprocal control of microRNAs by Hippo and TAZ signaling in breast cancer
Bjørn I. Gustafsson, Erik Berg, Axel Karlsson et al. (4 authors)
Authorea (Authorea) Open Access
Published: Nov 2023
854 days after retraction
MiRNAs Play a Functional Role in the Development of In Situ Breast Carcinoma
J Wiśniewski, Agnieszka Kozlowski
Authorea (Authorea) Open Access
Published: Nov 2023
854 days after retraction
Relationship between microRNA-9 and breast cancer
Alex Johannsson, Alex Johannsson, Lakshmi Sharma et al. (9 authors)
Authorea (Authorea) Open Access
Published: Nov 2023
854 days after retraction
In the age of microRNAs, Triple-Negative Breast Cancer
M Chen
Authorea (Authorea) Open Access
Published: Nov 2023
854 days after retraction
Biomarkers in breast cancer liquid biopsies: cell-free microRNAs and extracellular vesicles
A. Costa, Alfonso Costa, Duarte Rafael Sampaio Pereira
Authorea (Authorea) Open Access
Published: Nov 2023
854 days after retraction
Using Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer is a Cutting-Edge Application of MicroRNA Profiling Technology
Steven Talbot
Authorea (Authorea) Open Access
Published: Nov 2023
854 days after retraction
Nutritional Considerations Regarding the Role of MicroRNAs in the Regulation of Obesity-Related Breast Cancer
Michael Rose, Mohammad Ghasan, Emilia Jones
Authorea (Authorea) Open Access
Published: Nov 2023
854 days after retraction
Breast cancer lncRNA-microRNA categories: new targets for therapeutic intervention
Lorenzo Bruno, Lorenzo Bruno, Luca Rossi
Authorea (Authorea) Open Access
Published: Nov 2023
854 days after retraction
Understanding the therapeutic potential of modulating miRNAs in the course of thyroid and breast cancer
S. Lindsey Davis, S. Lindsey Davis, Hao Chen
Authorea (Authorea) Open Access
Published: Nov 2023
1 citation
853 days after retraction
Pathway study and systematic evaluation of microRNAs involved in anthracycline- induced cardiotoxicity in breast cancer patients
Xu Xiang
Authorea (Authorea) Open Access
Published: Nov 2023
853 days after retraction
The involvement of miRNA and lncRNA in the triple-negative breast cancer
Mohamad Sadeghifar khorami, Mohamad Sadeghifar Khorami, Sima Tavakoli
Authorea (Authorea) Open Access
Published: Sep 2023
789 days after retraction
An epigenetic modulator with promising therapeutic impacts against gastrointestinal cancers: A mechanistic review on microRNA-195
Amirhossein Davoodvandi, Mahdi Rafiyan, Zatollah Asemi et al. (4 authors)
Pathology - Research and Practice
Published: Jul 2023
6 citations
724 days after retraction
Landscape of NcRNAs involved in drug resistance of breast cancer
Yujuan Kang
Clinical & Translational Oncology Open Access
Published: Apr 2023
10 citations
642 days after retraction
CCAT2 knockdown inhibits cell growth, and migration and promotes apoptosis through regulating the hsa-mir-145-5p/AKT3/mTOR axis in tamoxifen-resistant MCF7 cells
Foruzan Moradi, Fatemeh Mohajerani, Majid Sadeghizadeh
Life Sciences
Published: Nov 2022
14 citations
486 days after retraction
Differentiation of Human Wharton Jelly Mesenchymal Stem Cells into Germ-Like Cells; emphasis on evaluation of Germ-long non-coding RNAs
Samira Ghasemi, Mohammad Shafiee, Gordon A. Ferns et al. (7 authors)
Molecular Biology Reports
Published: Oct 2022
1 citation
458 days after retraction
Research Progress of Long Non-Coding RNA GAS5 in Malignant Tumors
Guohong Lin, Tianzhun Wu, Xing Gao et al. (5 authors)
Frontiers in Oncology Open Access
Published: Jun 2022
41 citations
349 days after retraction
LINC00094/miR-19a-3p/CYP19A1 axis affects the sensitivity of ER positive breast cancer cells to Letrozole through EMT pathway
Xiang Yuan, Hui Liu, Hao Hu et al. (12 authors)
Aging Open Access
Published: Jun 2022
17 citations
323 days after retraction
The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer
Pingting Ye, Lei Feng, Shuo Shi et al. (4 authors)
Cancers Open Access
Published: Apr 2022
36 citations
283 days after retraction
New therapy strategies in the management of breast cancer
Sevgi Yardım-Akaydın, Bensu Karahalıl, Sultan Nacak Baytaş
Drug Discovery Today
Published: Mar 2022
27 citations
251 days after retraction
Metformin reverses tamoxifen resistance through the lncRNA GAS5-medicated mTOR pathway in breast cancer
Yiyan Jiang, Ting Qian, Su‐Xia Li et al. (5 authors)
Annals of Translational Medicine Open Access
Published: Mar 2022
19 citations
230 days after retraction
Long Noncoding RNA GAS5: A New Factor Involved in Bone Diseases
Zimo Zhou, Jiahui Chen, Ying Huang et al. (6 authors)
Frontiers in Cell and Developmental Biology Open Access
Published: Jan 2022
23 citations
196 days after retraction
LncRNA4930473A02Rik promotes cardiac hypertrophy by regulating TCF7 via sponging miR-135a in mice
Jing Ren, Hanping Qi, Chao Song et al. (10 authors)
Cell Death Discovery Open Access
Published: Dec 2021
9 citations
146 days after retraction
A Three lncRNA Set: AC009975.1, POTEH-AS1 and AL390243.1 as Nodal Efficacy Biomarker of Neoadjuvant Therapy for HER-2 Positive Breast Cancer
Zhao Bi, Pengfei Qiu, Yue Zhang et al. (8 authors)
Frontiers in Oncology Open Access
Published: Dec 2021
2 citations
145 days after retraction
Mycobacterium tuberculosis ESAT6 modulates host innate immunity by downregulating miR-222-3p target PTEN
Zonghai Chen, Tāo Luò, Pengjiao Ma et al. (10 authors)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease Open Access
Published: Oct 2021
9 citations
103 days after retraction
MicroRNAs as a clue to overcome breast cancer treatment resistance
Iris Garrido‐Cano, Birlipta Pattanayak, Anna Adam‐Artigues et al. (8 authors)
Cancer and Metastasis Reviews Open Access
Published: Sep 2021
22 citations
63 days after retraction
lncRNA and breast cancer: Progress from identifying mechanisms to challenges and opportunities of clinical treatment
Xin Jin, Wei Du, Wentao Huang et al. (7 authors)
Molecular Therapy — Nucleic Acids Open Access
Published: Aug 2021
82 citations
36 days after retraction
From Micro to Long: Non-Coding RNAs in Tamoxifen Resistance of Breast Cancer Cells
Jéssica Fernanda Barazetti, Tayana Shultz Jucoski, Tamyres Mingorance Carvalho et al. (10 authors)
Cancers Open Access
Published: Jul 2021
16 citations
8 days after retraction
Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells
Penn Muluhngwi, Carolyn M. Klinge
Cancers Open Access
Published: Jul 2021
20 citations
Same day as retraction
Effects of MicroRNA-22 (miR-222) on Non-Small-Cell Lung Carcinoma (NSCLC) Cells Apoptosis and Proliferation Through Protein Kinase B/Mammalian Target of Rapamycin (AKT/mTOR) Signaling Pathway
Xiaowei Xie, Jiansheng Lin, Mingqiang Kang et al. (4 authors)
Journal of Biomaterials and Tissue Engineering
Published: Jul 2021
13 days before retraction
Long Noncoding RNA GAS5 in Breast Cancer: Epigenetic Mechanisms and Biological Functions
Е. А. Филиппова, М. В. Фридман, A. M. Burdennyy et al. (8 authors)
International Journal of Molecular Sciences Open Access
Published: Jun 2021
73 citations
20 days before retraction
Endocrine resistance and epigenetic reprogramming in estrogen receptor positive breast cancer
Foteinos‐Ioannis Dimitrakopoulos, Αναστασία Κοττόρου, Aspasia Tzezou
Cancer Letters
Published: May 2021
26 citations
45 days before retraction
A Long Noncoding RNA, GAS5 Can Be a Biomarker for Docetaxel Response in Castration Resistant Prostate Cancer
Yuting Shan, Yingbo Huang, Adam M Lee et al. (6 authors)
Frontiers in Oncology Open Access
Published: May 2021
9 citations
54 days before retraction
Long non-coding RNAs in head and neck squamous cell carcinoma: Diagnostic biomarkers, targeted therapies, and prognostic roles
Xiang Meng, Zifei Wang, Qiuyue Lou et al. (8 authors)
European Journal of Pharmacology
Published: Apr 2021
17 citations
82 days before retraction
LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack
Jaganathan Venkatesh, Marie‐Claire D. Wasson, Justin M. Brown et al. (5 authors)
Cancer Letters Open Access
Published: Apr 2021
145 citations
89 days before retraction
LncRNA UCC promotes epithelial–mesenchymal transition via the miR-143-3p/SOX5 axis in non-small-cell lung cancer
Ri Chen, Zhang Chun-fan, Yuanda Cheng et al. (6 authors)
Laboratory Investigation Open Access
Published: Apr 2021
20 citations
99 days before retraction
LncRNA SNHG16 contributes to osteosarcoma progression by acting as a ceRNA of miR-1285-3p
Xiao Xiao, Ge Jiang, Shengtao Zhang et al. (8 authors)
BMC Cancer Open Access
Published: Apr 2021
16 citations
99 days before retraction
MicroRNA-497-5p Is Downregulated in Hepatocellular Carcinoma and Associated with Tumorigenesis and Poor Prognosis in Patients
Linlin Tian, Bin Qian, Xiaohui Jiang et al. (11 authors)
International Journal of Genomics Open Access
Published: Mar 2021
15 citations
120 days before retraction
Quick Stats
Total Citations: 129
Years Since Retraction: 4.3 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Insulin-like Growth Factor-1 Induces Adhesion and Migration…
Cancer Research • 0 citations
Effects of Oligonucleotide N3′→P5′ Thio-phosphoramidate (GR…
Cancer Research • 0 citations
The therapeutic potential of human adipose-derived mesenchy…
Cancer Letters • 85 citations
Effect of miR-25 on Proliferation of Nasopharyngeal Carcino…
BioMed Research International • 16 citations
(5E,7E)-4,5,6 Trihydroxy-3-(hydroxymethyl)tetrahydro-2H-pyr…
Bioinorganic Chemistry and Applications • 6 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice